4225 EXECUTIVE SQUARE, LA JOLLA, CA
Changes in Board, Management or Compensation
News, Material Contracts
Advancing Dual - Pathway Biologic Candidates in Autoimmune and Inflammatory Diseases September 2025
To Participate in the Cantor Fitzgerald Global Healthcare Conference
Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
Announces Chief Financial Officer Transition
Investor Presentation
To Present at the Jefferies Global Healthcare Conference
Q2
Q1
FY 2024
Q3
Q1 amended
FY 2023
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Prospectus Filed Pursuant to Rule 425
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership